top of page

GASTROENTEROLOGIST LETTER

Jul 29, 2024
7 min read

Updated: 6 days ago

This letter is for you to give to your gastroenterologist, so they understand how Lyme disease and its co-infections can affect the gut and liver, take you seriously and look deeper. Copy and paste it into an email or your patient portal, or print this page and bring it to your appointment. Add your name at the bottom. Every point is backed by a source listed at the end, so your doctor can check it for themselves.


There is a quick-view graphic with the key points at the bottom of this post.


COPY FROM HERE


Dear Doctor,


Thank you for taking the time to read this. Because of my Lyme disease (and/or tick-borne co-infections), I'm asking you to look carefully at my gut symptoms. I'm not asking you to have all the answers. I'm asking you to keep an open mind, because a lot of new research on Lyme and the gut has come out in the last few years.


WHAT ILADS TEACHES


- The International Lyme and Associated Diseases Society (ILADS) teaches that Lyme is a clinical diagnosis. Lab results can support it, but on their own they can't make or rule out the diagnosis, so a negative test does not rule out Lyme.


- Fewer than 30% of people with Lyme in the U.S. remember a tick bite, and fewer than 20% of Lyme rashes look like the classic bull's-eye. ILADS also notes that some patients have flu-like symptoms with no rash, or no memory of one, and that doctors should still consider Lyme where it is common, even without that sign.


- ILADS notes that the Lyme bacterium can reach any organ or tissue, and lists gastrointestinal symptoms among the common symptoms of disseminated and late Lyme disease.


- ILADS notes that 4% to 45% of Lyme patients in endemic areas also have a tick-borne co-infection, and that untreated co-infections can make people sicker and may keep Lyme treatment from working.


- ILADS notes that Babesia and Anaplasma may come with elevated liver enzymes.


- In May 2026, the U.S. Department of Health and Human Services (HHS) announced a partnership with ILADS. Patients can now find ILADS's clinician locator through hhs.gov/lyme.


- Please know there are two different medical guidelines for Lyme, one from ILADS and one from the IDSA. In its final report to Congress (2022), the federal Tick-Borne Disease Working Group asked that federal websites acknowledge there are divergent views on diagnosing and treating persistent and chronic Lyme.


WHAT TO KNOW ABOUT LYME TESTING


- Standard tests miss many infections. A 2026 study in the Journal of Clinical Microbiology found the four FDA-cleared two-tier testing methods it studied missed 64% to 78% of early Lyme cases at the first blood draw.


- IGeneX is a CLIA-certified lab licensed by New York State, and its Lyme ImmunoBlots are the foundation of two FDA-cleared test kits (IgG 2024, IgM 2025). A positive result from IGeneX deserves to be evaluated, not dismissed.


- Many states have Lyme laws. Maryland and Rhode Island laws require that patients be told a negative Lyme test does not necessarily mean they don't have Lyme.


LYME CAN AFFECT THE GUT AND LIVER


- Johns Hopkins and UC Davis (Journal of Experimental Medicine, 2026): in mice, Lyme bacteria quickly disrupted the gut's protective barrier, causing a "leaky gut." Patients with early Lyme had similar changes in their blood, which tracked with their symptoms and liver test results, and these had largely settled 6 months later, after antibiotic treatment.


- Northwestern University (Science Translational Medicine, 2025): in mice given pieces of the Lyme bacterium's cell wall, the pieces collected in the liver, and two liver enzymes were still raised 35 days later. This was an animal study.


- University of Kentucky (mBio, 2025, funded by Global Lyme Alliance): in monkeys, Lyme infection and antibiotic treatment led to a loss of helpful gut bacteria that keep the gut lining healthy. This was an animal study.


CO-INFECTIONS CAN AFFECT THE GUT TOO


- Anaplasmosis: the CDC states that gastrointestinal symptoms (nausea, vomiting, diarrhea, loss of appetite) happen in about 20% of cases, and that elevated liver enzymes are a common lab finding.


- Ehrlichiosis: the CDC lists nausea, vomiting, diarrhea and loss of appetite, along with elevated liver enzymes.


- Rocky Mountain spotted fever: the CDC notes abdominal pain that may mimic appendicitis, and elevated liver enzymes.


- Babesia: a Yale review (Pathogens, 2021) lists nausea and vomiting, sometimes an enlarged spleen or liver, and elevated liver enzymes.


ALPHA-GAL SYNDROME (FROM TICK BITES)


- The American Gastroenterological Association (Clinical Gastroenterology and Hepatology, 2023) recognizes that alpha-gal syndrome can show up mainly or only with gut symptoms, such as belly pain, diarrhea, nausea or vomiting, and wrote to increase awareness among gastroenterologists.


- A CDC survey of 1,500 primary care providers, published in 2023, found that 42% had never heard of alpha-gal syndrome. HHS (May 2026) reports that, according to CDC estimates, nearly 500,000 Americans are living with alpha-gal syndrome, and the true number may be higher.


NERVES, POTS AND GUT MOTILITY


- Johns Hopkins researchers (Frontiers in Neurology, 2024) reviewed dysautonomia after Lyme. They note that slow gut movement often happens with dysautonomia and may cause small intestinal bacterial overgrowth (SIBO), and that intestinal pseudo-obstruction and constipation have been reported after acute Lyme.


- A 2026 review of 19 studies and 8,268 POTS patients (Neurogastroenterology and Motility) found that nearly 6 in 10 had gut symptoms. Nausea was the most common (70.1%), about 1 in 4 had IBS, and about 36% had mast cell activation syndrome.


MAST CELLS AND THE GUT


- Dr. Leonard Weinstock, Dr. Lawrence Afrin and colleagues (Digestive Diseases and Sciences, 2020) wrote a mast cell activation syndrome primer for gastroenterologists. They note that gut symptoms are common in these patients, are often mistaken for functional GI disorders, and that patients face significant delays in diagnosis.


- Dr. Matthew Hamilton of Harvard (Current Gastroenterology Reports, 2024) explains that mast cell activation syndrome may explain IBS-type symptoms.


GUT PROBLEMS AFTER AN INFECTION ARE WELL RECOGNIZED


- A large 2024 review in Gut (47 studies, more than 28,000 people) found that 14.5% of people developed IBS after a stomach or intestinal infection (gastroenteritis), and for 39.8% of them it was still there more than 5 years later.


WHAT I'M ASKING


- Please listen to my history and symptoms, even if my tests look normal.


- Please don't rule out Lyme because I don't remember a tick bite or never saw a rash.


- Please consider Lyme, its co-infections and alpha-gal syndrome when my gut symptoms aren't explained, and use your judgment on which tests fit my symptoms, such as liver enzyme, co-infection, alpha-gal, SIBO or mast cell testing.


- If this isn't an area you treat, please help me find a doctor who does. ILADS's clinician locator is available through hhs.gov/lyme.


- Being believed matters to me. In a Johns Hopkins study, post-treatment Lyme patients who felt dismissed by providers had worse symptoms and quality of life (Rebman et al., 2024). Dr. Robert Bransfield (Rutgers, 2017) found that Lyme and associated diseases contributed to suicidal thoughts in some people who were not suicidal before, and that negative attitudes toward Lyme from family, friends and doctors may add to that risk.


- Please work with me as a partner. I want to get better, and I believe we can do that together.


WHERE THIS RESEARCH COMES FROM


The studies in this letter include research from Johns Hopkins, UC Davis, Northwestern, Yale, Harvard, Rutgers and the University of Kentucky, and from research centers in Australia, Italy and the United Kingdom. The 2026 testing study comes from the Bay Area Lyme Foundation's Lyme Disease Biobank, and the letter also draws on FDA reviews and state Lyme laws.


Thank you for your time, your care and your willingness to learn more about this illness with me.


Sincerely,


(Your name)


SOURCES

Horn et al. - Evaluation of Standard and Modified Two-Tiered Testing Algorithms Using Well-Characterized Early Lyme Disease Samples (Journal of Clinical Microbiology, 2026)

IGeneX - Licenses and Certifications

IGeneX - FDA Clearance

FDA 510(k) Decision Summary - iDart Lyme IgG ImmunoBlot Kit, K233367 (August 2024)

FDA 510(k) Decision Summary - iDart Lyme IgM ImmunoBlot Kit, K242872 (June 2025)

Maryland Health-General Section 20-1701

Rhode Island General Laws Section 5-37.5-6, Lyme disease testing information disclosure

ILADS - Lyme Disease Basics for Providers (updated 2026)

HHS - HHS Unveils Sweeping Plan to Combat Lyme Disease and Advance Treatment (May 2026)

HHS - Lyme Disease (Clinician Locator)

HHS Tick-Borne Disease Working Group - 2022 Report to Congress

Journal of Experimental Medicine - Borrelia burgdorferi disrupts gut barrier functions and microbiota-antibody interactions (Johns Hopkins, 2026)

Science Translational Medicine - Lyme bacterium cell wall persists in tissues (Northwestern, 2025)

mBio - Lyme infection, antibiotics and the gut microbiome in monkeys (June 2025)

CDC - Anaplasmosis: Clinical Signs and Symptoms

CDC - Ehrlichiosis: Clinical Signs and Symptoms

CDC - Rocky Mountain Spotted Fever: Clinical Signs and Symptoms

Pathogens - Yale review of babesiosis (November 2021, older source, still worth reading)

Clinical Gastroenterology and Hepatology - AGA Clinical Practice Update on Alpha-Gal Syndrome (2023)

CDC MMWR - Health Care Provider Knowledge of Alpha-gal Syndrome (July 2023)

CDC - Emerging tick bites and alpha-gal syndrome press release (July 2023)

Frontiers in Neurology - Dysautonomia following Lyme disease (Johns Hopkins, February 2024)

Neurogastroenterology and Motility - Gastrointestinal Symptoms and Systemic Comorbidities in Patients With POTS (April 2026)

Digestive Diseases and Sciences - Mast Cell Activation Syndrome: A Primer for the Gastroenterologist (2020, older source, still worth reading)

Current Gastroenterology Reports - Mast Cell Activation Syndrome and Gut Dysfunction (2024)

Gut - IBS and functional dyspepsia after acute gastroenteritis (Porcari et al., 2024)

Rebman AW, Yang T, Aucott JN - Invalidation by medical professionals in post-treatment Lyme disease (Scientific Reports, 2024)

Bransfield RC - Suicide and Lyme and associated diseases (Neuropsychiatric Disease and Treatment, 2017, older source, still worth reading)


Comments


bottom of page